Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Raleigh, North Carolina
- Most recent report
- 8-K, filed Oct 9, 2026
- Incorporated
- Delaware
- Filings on record
- 34 filings
- On EDGAR
- CIK 1903784
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 1
News 4
Prospectuses and Registrations 5
Ownership 8 of 17
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 3 Insider reported their initial holding Sep 28, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 8, 2026
Other 7
- EFFECT Notice that a registration became effective Aug 11, 2026
- CERT Exchange certified a listing Aug 11, 2026
- 8-A12B Registration of a security for exchange listing Aug 10, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jun 30, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Apr 2, 2026
- DRS Draft registration statement, submitted confidentially Feb 20, 2026
- D Jan 7, 2026
Everything here comes from Vogenx, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.